Aegerion Pharma (AEGR) Announces Common Offering
Tweet
Share
E-mailGet Alerts AEGR Hot Sheet
Join SI Premium – FREE
Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR), intends to offer for sale its common stock in an underwritten public offering. All shares in the offering are being sold by Aegerion.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karman Line Acquisition closes $200M IPO on Nasdaq
- Aveanna Healthcare prices secondary offering at $11.75 per share
- Pyxis Oncology (PYXS) files for 39.2M share offering by selling stockholders
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
